Infectious Diseases 1001 - Infectious Disease Alert - Jan 01, 2006

Target Audience:

This activity is intended for the infectious disease specialist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Stanford;
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Co-editor
Joseph F. John, Jr., MD
Chief
Medical Subspecialty Services
Ralph H. Johnson Veterans Administration Medical Center
Professor of Medicine
Medical University of South Carolina
Charleston, SC

Associate Editors
Robert Muder, MD
Hospital Epidemiologist
Pittsburgh VA Medical Center
Pittsburgh
Section Editor, Hospital Epidemiology

Hal B. Jenson, MD, FAAP
Chair
Department of Pediatrics
Director
Center for Pediatric Research
Eastern Virginia Medical School and
Children?s Hospital of the King?s Daughters
Norfolk, VA

J. Peter Donnelly, PhD
Clinical Microbiologist
University Hospital
Nijmegen, The Netherlands
Section Editor, Microbiology

Dean L. Winslow, MD, FACP
Chief
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine
Section Editor, HIV

Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases;
Santa Clara Valley Medical Center
Section Editor, Updates
Section Editor, HIV

Subjects:

  • Dissemination of Metallo-β-Lactamase Gene blaIMP-4 Among Gram-Negative Pathogens in a Clinical Setting
  • Immunogenicity and Safety of the New MMRV Vaccine
  • Cumitech Blood Cultures
  • The Changing (Uglier) Face of CDAD
  • Updated Guidelines for Antiretroviral Therapy—2005
  • Dysregulation of Bacterial Proteolytic Machinery
  • Updates

Objectives:

  • to discuss diagnosis and treatment of infectious diseases
  • present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • present the latest information regarding pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • present prevalence/surveillance data for various diseases, such as AIDS, tuberculosis, malaria, and pneumonia
  • discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapeutic drugs

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Co-editor, Joseph F. John, Jr., MD does research for Merck, is a consultant for Cubist, Roche, and bioMerieux, and is on the speaker’s bureau for Pharmacia, GSK, Merck, Bayer, and Wyeth.

Associate Editor, Robert Muder, MD does research for Aventis and Pharmacia.

Associate Editor, Hal B. Jenson, MD, FACP is on the speaker’s bureau for Merck.

Associate Editor, J. Peter Donnelly, PhD is a consultant for Ortho Biotech, and does research for Janssen, Merck, Novartis, Numico, Pharmacia, and Pfizer.

Associate Editor, Dean L. Winslow, MD, FACP is a consultant for Bayer Diagnostics and Pfizer/Agouron, and is on the speaker’s bureau for Pfizer/Agouron.

Associate Editor, Carol Kempner, MD, reports that she is on the speaker’s bureau for Pfizer, GlaxoSmithKline, and Agouron and does research for Agouron, GlaxoSmithKline, and Beecham Pharmaceuticals.

Peer Reviewer, Connie Price, MD reports no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Copyright 2006 AHC Media. All rights reserved.